Cytotoxic Effect of the Paku Atai Merah (Angiopteris ferox Copel) Fraction on MCF-7 and HeLa Cells and its Compound Profile by GC-MS
Article Sidebar
-
Cancer, Cytotoxic, GC-MS, MCF-7, HeLa
Abstract
Cancer is a condition of abnormal cell proliferation of tissue cells in the body that becomes malignant. It can attack other parts of the body and affect the normal function of the body organs. The sample used in this study was tubers of paku atai merah (Angiopteris ferox Copel), then extracted using 96% ethanol eluent to obtain a thick extract. The ethanolic extract of A. ferox was fractionated using column chromatography to get the active fraction to characterize the compound using thin-layer chromatography and gas chromatography-mass spectroscopy (GC-MS) and tested its cytotoxic effectiveness on MCF-7 and HeLa cancer cells. The results of this study were obtained from fractionation using the column chromatography method to get sub-fraction C and the results of compound characterization using GC-MS and obtained variations in the class of compounds contained in the sample: amino acids, glucosinolates, alkaloids, flavonoids, and terpenoids. Based on the cytotoxic effect test of sub-fraction C on MCF-7 cells, the results obtained moderate cytotoxic effects with an IC50 value of 61.027 µg/mL, and HeLa cells had an IC50 value of 521.03 µg/mL, which was categorized as having a weak cytotoxic effect. Based on the results obtained from this study, it can be concluded that sub-fraction C of A. ferox tubers has a cytotoxic effect on MCF-7 cells to be used as a reference for tracing pure compounds from A. ferox tuber.
Full text article
References
2. Aisyah AN, Nur S, Lukitaningsih E, Rumiyati, Burhan A, Adjara SM, et al. Efek Sitotoksik Ekstrak dan Fraksi Umbi Paku Atai Merah (Angiopteris ferox Copel) Terhadap Sel Kanker Payudara T47D. J Farmasi Galenika (Galenika J Pharm). 2020;6(2):319-27. doi:10.22487/j24428744.2020.v6.i2.15255
3. Hassanpour SH, Dehghani M. Review of cancer from perspective of molecular. J Cancer Res Pract. 2017;4(4):127-9. doi:10.1016/j.jcrpr.2017.07.001
4. Sever R, Brugge JS. Signal Transduction in Cancer. Cold Spring Harb Perspect Med. 2015;5(4):a006098. doi:10.1101/cshperspect.a006098
5. Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L, et al. Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 2018;5(2):77-106. doi:10.1016/j.gendis.2018.05.001
6. Park SH, Hoang T, Kim J. Dietary Factors and Breast Cancer Prognosis among Breast Cancer Survivors: A Systematic Review and Meta-Analysis of Cohort Studies. Cancers. 2021;13(21):5329. doi:10.3390/cancers13215329
7. Nur S, Aisyah AN, Lukitaningsih E, Rumiyati, Juhardi RI, Andirah R, et al. Evaluation of antioxidant and cytotoxic effect against cancer cells line of Angiopteris ferox Copel tuber and its compounds by LC-MS analysis. J Appl Pharm Sci. 2021;11(8):54-61. doi:10.7324/JAPS.2021.110808
8. Debele DT, Muzazu SG, Heraro KD, Ndalama MT, Mesele BW, Haile DC, et al. New approaches and procedures for cancer treatment: Current perspectives. SAGE Open Med. 2021;9:20503121211034366. doi:10.1177/20503121211034366
9. Schirrmacher V. From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review). Int J Oncol. 2019;54(2):407-19. doi:10.3892/ijo.2018.4661
10. Naja F, Anouti B, Shatila H, Akel R, Haibe Y, Tfayli A. Prevalence and Correlates of Complementary and Alternative Medicine Use among Patients with Lung Cancer: A Cross-Sectional Study in Beirut, Lebanon. Evid Based Complement Alternat Med. 2017;2017:8434697. doi:10.1155/2017/8434697
11. Chikara S, Nagaprashantha LD, Singhal J, Horne D, Awasthi S, Singhal SS. Oxidative Stress and Dietary Phytochemicals: Role in Cancer Chemoprevention and Treatment. Cancer Lett. 2018;413:122-34. doi:10.1016/j.canlet.2017.11.002
12. Iqbal J, Abbasi BA, Batool R, Mahmood T, Ali B, Khalil AT, et al. Potential phytocompounds for developing breast cancer therapeutics: Nature’s healing touch. Eur J Pharmacol. 2018;827:125-48. doi:10.1016/j.ejphar.2018.03.007
13. Singh S, Sharma B, Kanwar SS, Kumar A. Lead Phytochemicals for Anticancer Drug Development. Front Plant Sci. 2016;7:1667. doi:10.3389/fpls.2016.01667
14. Seca AML, Pinto DCGA. Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application. Int J Mol Sci. 2018;19(1):263. doi:10.3390/ijms19010263
15. Nur S, Aisyah AN, Lukitaningsih E, Paliling SR, Rumiyati, Marwati. Isolation of Secondary Metabolites from Paku Atai Merah (Angiopteris ferox Copel) Tubers. Plant Cell Biotechnol Mol Biol. 2020;21(69-70):10-7.
16. Nur S, Mubarak F, Jannah C, Winarni DA, Rahman DA, Hamdayani LA, et al. Total phenolic and flavonoid compounds, antioxidant and toxicity profile of extract and fractions of paku atai tuber (Angiopteris ferox Copel). Food Res. 2019;3(6):734-40. doi:10.26656/fr.2017.3(6).135
17. Basma AA, Zakaria Z, Latha LY, Sasidharan S. Antioxidant activity and phytochemical screening of the methanol extracts of Euphorbia hirta L. Asian Pac J Trop Med. 2011;4(5):386-90. doi:10.1016/s1995-7645(11)60109-0
18. Zhang QW, Lin LG, Ye WC. Techniques for extraction and isolation of natural products: a comprehensive review. Chin Med. 2018;13:20. doi:10.1186/s13020-018-0177-x
19. Dai J, Mumper RJ. Plant Phenolics: Extraction, Analysis and Their Antioxidant and Anticancer Properties. Molecules. 2010;15(10):7313-52. doi:10.3390/molecules15107313
20. Li G, Ding K, Qiao Y, Zhang L, Zheng L, Pan T, et al. Flavonoids Regulate Inflammation and Oxidative Stress in Cancer. Molecules. 2020;25(23):5628. doi:10.3390/molecules25235628
21. Kopustinskiene DM, Jakstas V, Savickas A, Bernatoniene J. Flavonoids as Anticancer Agents. Nutrients. 2020;12(2):457. doi:10.3390/nu12020457
22. Marwati M, Anggriani A, Burhan A, Awaluddin A, Nur S, Dharmayanti R, et al. Antioxidant Activity and Cytotoxicity Against WiDR Cell and Vero Cell of The Karamunting (Rhonomyrtus tomentosa L.) Leaves Ethanol Extract. Indones J Pharm Sci Technol. 2021;8(3):111-7. doi:10.24198/ijpst.v8i3.26769
23. Suvarna V, Murahari M, Khan T, Chaubey P, Sangave P. Phytochemicals and PI3K Inhibitors in Cancer-An Insight. Front Pharmacol. 2017;8:916. doi:10.3389/fphar.2017.00916
Authors
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors continue to retain the copyright to the article if the article is published in the Borneo Journal of Pharmacy. They will also retain the publishing rights to the article without any restrictions.
Authors who publish in this journal agree to the following terms:
- Any article on the copyright is retained by the author(s).
- The author grants the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share work with an acknowledgment of the work authors and initial publications in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of published articles (e.g., post-institutional repository) or publish them in a book, with acknowledgment of their initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their websites) prior to and during the submission process. This can lead to productive exchanges and earlier and greater citations of published work.
- The article and any associated published material are distributed under the Creative Commons Attribution-ShareAlike 4.0 International License.
Article Details
